MRD-guided retreatment with anti-CD20 antibodies may improve survival outcomes in high-risk, relapsed CLL patients by initiating therapy before clinical relapse. The study showed MRD-triggered ...
A chromosome is a package of DNA that exists inside the nucleus of a cell. A karyotype refers to the unique collection of chromosomes present in a person’s cells. Acute myeloid leukemia (AML) is a ...
Please provide your email address to receive an email when new articles are posted on . Higher mutational burden linked with shorter time to first treatment in patients with CLL. Researchers did not ...
Complex karyotype (CK) predicts poor prognosis in chronic lymphocytic leukemia (CLL). CK detection is routinely assessed by chromosome banding analysis (CBA) or chromosomal microarrays (CMA), although ...
Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk ...
An overview of the treatments for chronic lymphocytic leukemia (CLL) and novel therapies on the horizon, including double and triple combination therapies, cellular therapies, and bispecific ...
Treatment of chronic lymphocytic leukemia (CLL) currently consists of two main approaches — continuous therapy with Bruton’s tyrosine kinase inhibitors and fixed-duration regimens combining venetoclax ...
Lisaftoclax monotherapy demonstrated significant and durable clinical efficacy and a manageable safety profile in patients with heavily pretreated BTK-refractory R/R CLL/SLL, underscoring its utility ...
Chronic myeloid leukemia (CML) is a rare blood cancer that develops in the bone marrow. Karyotyping is a genetic technique doctors use to diagnose CML and choose more effective treatments. Karyotyping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results